Homo sapiens myocyte enhancer factor 2A (MEF2A), transcript variant 1
Synonyms:
ADCAD1; mef2; RSRFC4; RSRFC9
Immunogen
The antiserum was produced against synthesized phosphopeptide derived from humanMEF2A around the phosphorylation site of threonine 312 (L-A-TP-P-V).
Buffer
phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Clone Name
Isotype
Species Reactivity
Human, Mouse, Rat
Concentration
1ug/ul
Purification
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography usingepitope-specific phosphopeptide. The antibody against non-phosphopeptide was removedby chromatography using non-phosphopeptide corresponding to the phosphorylation site. (Protein A or G Sepharose)
Guaranteed Application *
IHC
Suggested Dilutions
IHC: 1:50-1:100
Background
Related Pathway
Adipogenesis
TGF Beta Signaling Pathway
* Shipping is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
